[ad_1]
Reulay, a virtual therapy platform that uses machine learning to relieve stress and anxiety, announced exciting results. A study conducted by a multi-billion-dollar health insurance company reported that the feasibility, safety and effectiveness of Reulay’s digital intervention have reached primary and secondary goals. The results show that Reulay’s carefully constructed brain-based virtual journey reduces negative attitudes, worries, tension and feelings of edge, which is an important step to eliminate stress in the workplace.
Dr. Srini Pillay, chief medical officer and co-founder of Reulay, a brain researcher, believes these findings are encouraging. Dr. Pillay, who used to carry out the outpatient anxiety program at Harvard University’s McLean Hospital, said: “People don’t realize that stress and anxiety are killers, not only themselves, but to a certain extent they have created genes that can be turned on. Change the pathway to cancer, heart disease, stroke, and neurodegenerative diseases (such as Alzheimer’s disease).”
He added that one of the advantages of Reulay’s patent-pending machine learning platform and its proprietary brain-based digital therapy is the ability to tailor treatments for individual users. “Everyone is unique, which is why Reulay takes a personalized approach to medicine.”
Reulay is now providing virtual reality interventions for organizations. Chief Executive Patrick Candela explained: “Work is a crime scene of stress and anxiety. Companies have realized that reducing stress every day is beneficial to their leaders and employees, reducing insurance costs, and positively impacting their financial bottom line. How valuable the impact is. Line.”
“Leaders now need more resilience and agility than ever before,” said Dr. Pillay of the Training Industry Association. The top 20 shakers in the world In the development of leadership.
Reulay also announced that Chris Scott has joined the team as chief business officer. Candela said: “We are very pleased that Chris has joined our mission. He has more than 20 years of experience as chief revenue officer and business development in chief technology startups, and has worked at Even Financial, Criteo and Google.”
“As a digital healthcare company, we are developing rapidly, investing a lot of money in research and development to provide evidence-based solutions that have the best domain expertise in the world. As the company adopts a hybrid work model, we see It is exciting for leaders and employees to embrace innovative companies with healthy solutions,” Candela commented.
About Reulay Inc:
Founded by leading psychiatrists, neuroscientists, and AI researchers, Reulay’s mission is to improve the quality of life and longevity of 2 billion people by creating effective, scalable, and affordable digital health therapies.
Reulay’s virtual treatment platform uses machine learning across biometrics, digital behavior, brain science, and epigenetics research to personalize evidence-based digital medicine that targets human biology for prevention and treatment.
Reulay is advancing a series of products involving VR, AR, mobile and web interventions to reduce stress and anxiety disorders and related chronic diseases such as cancer, stroke, heart disease and neurodegenerative diseases.
View the source code version on businesswire.com: https://www.businesswire.com/news/home/20210527005277/en/
[ad_2]
Source link
